BlackRock Advisors’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$292K Sell
11,645
-299
-3% -$7.06K ﹤0.01% 2515
2016
Q3
$279K Buy
11,944
+1,068
+10% +$25.1K ﹤0.01% 2500
2016
Q2
$217K Buy
10,876
+136
+1% +$2.54K ﹤0.01% 2558
2016
Q1
$182K Sell
10,740
-38,696
-78% -$793K ﹤0.01% 2607
2015
Q4
$1.1M Buy
49,436
+35,091
+245% +$731K ﹤0.01% 1665
2015
Q3
$243K Sell
14,345
-92,671
-87% -$1.44M ﹤0.01% 2606
2015
Q2
$1.47M Sell
107,016
-40,858
-28% -$543K ﹤0.01% 1411
2015
Q1
$2.02M Buy
147,874
+1,548
+1% +$17.9K ﹤0.01% 1222
2014
Q4
$1.55M Buy
146,326
+2,949
+2% +$34.9K ﹤0.01% 1296
2014
Q3
$1.79M Sell
143,377
-200
-0.1% -$2.79K ﹤0.01% 1204
2014
Q2
$1.96M Sell
143,577
-1,604
-1% -$21K ﹤0.01% 1182
2014
Q1
$1.75M Buy
145,181
+1,062
+0.7% +$12.2K ﹤0.01% 1230
2013
Q4
$1.77M Buy
144,119
+308
+0.2% +$3.61K ﹤0.01% 1235
2013
Q3
$1.46M Buy
143,811
+89,207
+163% +$834K ﹤0.01% 1251
2013
Q2
$490K Buy
+54,604
New +$550K ﹤0.01% 1843

Other funds holding OME

BlackRock Advisors's OME Position: Q4 2016 in Review

BlackRock Advisors reduced its Omega Protein (OME) stake by 2.5% in Q4 2016, selling an estimated $7.06K and leaving 11,645 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

BlackRock Advisors first reported a position in OME in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.02M in Q1 2015. 142 funds tracked by Wall St. Rank hold OME as of Q4 2016.

  • BlackRock Advisors held 11,645 shares of Omega Protein worth $292K as of Q4 2016.
  • BlackRock Advisors sold 299 Omega Protein shares in Q4 2016, an estimated $7.06K.
  • Omega Protein made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2515 holding.
  • BlackRock Advisors first reported a position in Omega Protein in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Omega Protein position peaked at $2.02M in Q1 2015.
  • 142 funds tracked by Wall St. Rank held Omega Protein as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.